These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7342838)

  • 1. [General schema for safety evaluation of residues of embryotoxic drugs (author's transl)].
    Delatour P; Boisseau J; Burgat V; Mergier P; Milhaud G; Richou-Bac L; Rico A; Siou G
    Ann Rech Vet; 1981; 12(2):215-8. PubMed ID: 7342838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Embryotoxic properties of drugs].
    Smol'nikova NM; Golovanova IV; Proĭnova VA; Skosyreva AM; Strekalova SN
    Farmakol Toksikol; 1982; 45(4):115-9. PubMed ID: 6751867
    [No Abstract]   [Full Text] [Related]  

  • 3. Albendazole : a comparison of relay embryotoxicity with embryotoxicity of individual metabolites.
    Delatour P; Parish RC; Gyurik RJ
    Ann Rech Vet; 1981; 12(2):159-67. PubMed ID: 7342833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of bone marrow in preclinical safety tests of new drugs (author's transl)].
    Berger J
    Cas Lek Cesk; 1982 Jan; 121(4):97-101. PubMed ID: 7060066
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of veterinary drugs during pregnancy of the dog].
    Landsbergen N; Pellicaan CH; Schaefers-Okkens AC
    Tijdschr Diergeneeskd; 2001 Nov; 126(22):716-22. PubMed ID: 11758478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the method of injecting into the yolk-sac in teratological studies in rabbits (author's transl)].
    Claussen U
    Arzneimittelforschung; 1975 Sep; 25(9):1434-6. PubMed ID: 1242669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system.
    Flick B; Talsness CE; Jäckh R; Buesen R; Klug S
    Toxicol Appl Pharmacol; 2009 Jun; 237(2):154-67. PubMed ID: 19281833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of human serum for studying malformations in whole embryo cultures.
    Beck F; Gulamhusein AP; Huxham IM
    Prog Clin Biol Res; 1985; 163C():265-70. PubMed ID: 3991629
    [No Abstract]   [Full Text] [Related]  

  • 11. Developmental toxicity of indium: embryotoxicity and teratogenicity in experimental animals.
    Nakajima M; Usami M; Nakazawa K; Arishima K; Yamamoto M
    Congenit Anom (Kyoto); 2008 Dec; 48(4):145-50. PubMed ID: 18983580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scientific basis in the setting of residue limits for veterinary drugs in food of animal origin taking into account the presence of their metabolites].
    Mitsumori K
    Eisei Shikenjo Hokoku; 1993; (111):148-9. PubMed ID: 7920562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model].
    Bertsche T; Haas M; Oberwittler H; Haefeli WE; Walter-Sack I
    Dtsch Med Wochenschr; 2006 May; 131(18):1016-22. PubMed ID: 16673226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The embryo-protective action of antifein derivatives in chloridin-induced teratogenesis].
    Bichevaia NK; Chebotar' NA; Aleksandrova IIa; Stepanov II; Klement'ev BI; Sapronov NS
    Ontogenez; 1999; 30(4):302-6. PubMed ID: 10519132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues.
    Delatour P; Garnier F; Benoit E; Longin C
    J Vet Pharmacol Ther; 1984 Jun; 7(2):139-45. PubMed ID: 6748156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primates in studies on the safety of drugs].
    Verschuere B; Collin A; Landsmann F; Fabre G; Famose F; Gouy D
    Pathol Biol (Paris); 1990 Mar; 38(3):221-4. PubMed ID: 2186341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone reduces ketoconazole-induced skeletal defects in rat fetuses.
    Amaral VC; Nunes GP
    Arch Toxicol; 2009 Sep; 83(9):863-71. PubMed ID: 19479239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the long-term effects of some pesticides.
    Ivanova-Chemishanska L; Vergieva T; Antonov G; Mirkova E
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(3):295-302. PubMed ID: 7440964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic and metabolic studies in the development of drugs].
    Vereczkey L
    Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.